Wednesday, February 21, 2018
Clinical Trials One Year Follow Up Prostate Cancer

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) Gains 10% After One-Year Follow Up To Phase 1...

OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) operates as a biopharmaceutical developer, which focuses on cancer and immunotherapy treatments. Shares of the biopharmaceutical company are rallying...
Brain Tumor Treatments Biotechnology 8K

Accurexa, Inc. (OTCQB: ACXA) Surges 50.50% After 8-K Filing Details of License Agreement with...

Accurexa, Inc. (OTCQB: ACXA) is engaged within the research and development of novel neurological therapies, which are designed to be directly delivered into specific...

Cancers Last Stand – GR-MD-02 Nearly Doubles Response Rate when added to Keytruda

Historic Phase 1a Efficacy Data Clearly Defined Approvable Pathway for GR-MD-02 Bidding War – Merck Do or Die Situation Platform Technology Case Increases...
Biotech Oncology Treatments Regional Agreement China

Oncolytics Biotech, Inc. (OTCQX: ONCYF) Jumps 35.10% After Entering Into $86.6 Million Regional Licensing...

Oncolytics Biotech, Inc. (OTCQX: ONCYF) is engaged as a biotechnology company that develops treatments for immune-oncolytics. Shares of the biotech company are jumping 35.10%...
Acquisition Agreement Medical Treatment Uplist

Sevion Therapeutics, Inc. (OTCQB: SVON) Rallies 19.23% After Acquisition Agreement With Eloxx Pharmaceuticals, Ltd.,...

Sevion Therapeutics, Inc. (OTCQB: SVON) is engaged as a biopharmaceutical company, which develops treatments for cancer and immunological diseases. Shares of the medical treatment...
Biotech Conference Professionals

Q BioMed, Inc. (OTCQB: QBIO) Dives 23% After Announcing Presentation at Biotech Conference in...

Q BioMed, Inc. (OTCQB: QBIO) operates as a biomedical company, which engages in licensing, acquisition, and provider of medical resources to other healthcare companies....
Biopharmaceuticals Cancer Tumor US Patent Third

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) Gains 17.86% After Receiving Third Cancer Combination US Patent

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) is a clinical-stage biotechnology company that develops treatments for tumors, cancers, and other ailments. Shares of the biotechnology company...
Community Hospital Collaboration Agreement

Southern Home Medical, Inc. (OTC Pink: SHOM) Jumps 38.46% After Collaboration Agreement Ads 32...

Southern Home Medical, Inc. (OTC Pink: SHOM) is engaged as a healthcare services and equipment company. Shares of the healthcare services provider is climbing...
bacteria-molecule-detection

Great Basin Scientific, Inc. (OTCQB: GBSN) Dives 50% Over The Past Three Trading Days...

Great Basin Scientific, Inc. (OTCQB: GBSN) engages in the development and commercialization of molecular diagnostic systems. Shares of the medical device company have been...
Emerging Growth Biotechnology Company

Corix Biosciences, Inc. (OTCQB: CXBS) – Patenting Cannabis and Hemp Strands for FDA Approval,...

Corix Biosciences, Inc. (OTCQB: CXBS), as the first major player for applications for cancer, the opioid epidemic, and other illnesses and diseases, will patent...

STAY CONNECTED

145,386FansLike
1,230FollowersFollow
1,283FollowersFollow
180SubscribersSubscribe

MOST POPULAR